ATAD3B inhibitors encompass a variety of chemicals that can influence the activity of the ATPase Family AAA Domain-Containing Protein 3B through indirect mechanisms. These compounds are typically characterized by their ability to modulate mitochondrial functions, given that ATAD3B is a mitochondrial protein involved in the regulation of the organelle's dynamics and its nucleoid structure. The inhibitors operate through diverse biochemical pathways, often targeting fundamental processes such as ATP synthesis, mitochondrial membrane potential, and the overall integrity of mitochondrial function. For instance, some of these chemicals can inhibit key enzymes in the electron transport chain, such as complex I or III, leading to a reduction in ATP synthesis. As ATP is a crucial energy source for various cellular functions, including those performed by ATAD3B, a decrease in ATP levels can consequently reduce the activity of ATAD3B.
The range of compounds also includes those that can disrupt mitochondrial dynamics, such as fusion and fission processes. Inhibitors that alter the normal cycling of mitochondrial division can impact the proper distribution and function of ATAD3B within the cell. Furthermore, some chemicals within this class can affect the transport of proteins into mitochondria, which may be crucial for ATAD3B's localization and function. Chemicals that modulate mitochondrial proteases can indirectly impact the stability and expression levels of ATAD3B by affecting protein quality control within the organelle. The effectiveness of these inhibitors relies on their capacity to permeate the mitochondrial membrane and to exert their action without direct interaction with ATAD3B, hence influencing its activity via alterations in the mitochondrial environment or the availability of essential molecules such as ATP. As such, this class of inhibitors is a diverse group of molecules that can exert complex effects on cellular bioenergetics and organelle dynamics, which are inextricably linked to the function of ATAD3B.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
Inhibits ATP synthase, reducing ATP levels and possibly affecting ATP-dependent functions of ATAD3B. | ||||||
Bongkrekic acid | 11076-19-0 | sc-205606 | 100 µg | $400.00 | 10 | |
Binds to the adenine nucleotide translocator, potentially altering mitochondrial ADP/ATP ratios and indirectly affecting ATAD3B. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Inhibits mitochondrial complex I, could reduce ATP production, influencing ATAD3B activity. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Inhibits complex III of the mitochondrial electron transport chain, could reduce ATP availability for ATAD3B. | ||||||
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $77.00 $153.00 $240.00 | 8 | |
Uncouples oxidative phosphorylation, potentially decreasing ATP levels and affecting ATAD3B. | ||||||
Mdivi-1 | 338967-87-6 | sc-215291 sc-215291B sc-215291A sc-215291C | 5 mg 10 mg 25 mg 50 mg | $67.00 $126.00 $251.00 $465.00 | 13 | |
A selective inhibitor of mitochondrial division, potentially affecting mitochondrial dynamics associated with ATAD3B. | ||||||